Exact Sciences (EXAS) Equity Ratio (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Equity Ratio data on file, last reported at 0.41 in Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.41, up 1.1% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.41 (up 1.1% YoY), and the FY2025 annual result was 0.41, up 1.1% from the prior year.
• Equity Ratio declined to 0.41 in Q4 2025 per EXAS's latest filing, from 0.42 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.54 in Q1 2021 and troughed at 0.41 in Q4 2024.
• A 5-year average of 0.48 and a median of 0.49 in 2023 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2021 and 2024: Equity Ratio surged 30.73% in 2021, then dropped 16.63% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.51 in 2021, then decreased by 3.56% to 0.49 in 2022, then dropped by 0.55% to 0.49 in 2023, then fell by 16.63% to 0.41 in 2024, then gained by 1.1% to 0.41 in 2025.
• Business Quant data shows EXAS's Equity Ratio at 0.41 in Q4 2025, 0.42 in Q3 2025, and 0.43 in Q2 2025.